An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance

DOI10.1080/03461238.2021.1930136MaRDI QIDQ5083402zbMATH OpenOpenAlexFDO

Authors Oytun Haçarız, Torsten Kleinow, Angus S. Macdonald

Publication date 20 June 2022

Published in Scandinavian Actuarial Journal (Search for Journal in Brave)

Copyright license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Full work available at URL https://doi.org/10.1080/03461238.2021.1930136

zbMATH Keywords

genetic epidemiologyadverse selectionlife insurancecascade genetic testingarrhythmogenic right ventricular cardiomyopathy

Mathematics Subject Classification ID

Actuarial mathematics (91G05) Epidemiology (92D30) Genetics and epigenetics (92D10)

Recommendations

• Genetics, insurance and hypertrophic cardiomyopathy
• Effective Underwriting in the Genetic Testing Era
• The genetics of breast and ovarian cancer. V: Application to income protection insurance
• A Model for Coronary Heart Disease and Stroke with Applications to Critical Illness Insurance Underwriting II: Applications
• A Model for Coronary Heart Disease and Stroke with Applications to Critical Illness Insurance Underwriting I: The Model

Cites work

• Genetics, insurance and hypertrophic cardiomyopathy

Cited in

(3)

• Genetics, insurance and hypertrophic cardiomyopathy
• Effective Underwriting in the Genetic Testing Era
• Lapse-supported life insurance and adverse selection

This page was built for publication: An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5083402)